title: Plasma hormones in patients with chronic heart failure before and early after orthotopic heart transplantation.
abstract: The aim of this prospective study was to investigate both vasoconstricting and vasodilating plasma hormones and plasma factors regulating the circulatory homeostasis in patients with endstage congestive heart failure before and early after orthotopic heart transplantation and to evaluate factors which may influence their regulation. 19 patients with endstage congestive heart failure were analyzed serially before and 3-4 weeks after orthotopic heart transplantation. A significant decrease in plasma concentrations of noradrenaline (457 +/- 202 vs. 204 +/- 88 pg/ml; p less than 0.001), adrenaline (43 +/- 32 vs. 26 +/- 11 pg/ml), atrial natriuretic peptide (341 +/- 218 vs. 139 +/- 64 pg/ml; p less than 0.005), cyclic guanosine monophosphate (13.8 +/- 7.8 vs. 6.6 +/- 2.2 pmol/ml, p less than 0.05) and in plasma renin activity (16.6 +/- 13.0 vs. 2.0 +/- 2.4 ng AI/ml/h; p less than 0.01) was found after transplantation. The data indicate that the marked increase in plasma catecholamine concentrations and renin activity in endstage congestive heart failure is reversible as early as 3-4 weeks after heart transplantation. This is most likely the consequence of normalization of cardiac function. While elevation of atrial natriuretic peptide and cyclic guanosine monophosphate as well as increased vasoconstrictor activity in heart failure appear to be related to impaired ventricular function, the persistent moderate elevation of both vasodilating agents after transplantation may be compensatory to counteract cyclosporin-induced arterial hypertension after heart transplantation.
authors.affiliation: Medizinische Klinik, Klinikum Innenstadt, Ludwig-Maximilians-Universität München.
authors.forename: C H
authors.initials: CH
authors.lastname: Spes
authors.forename: C E
authors.initials: CE
authors.lastname: Angermann
authors.forename: R
authors.initials: R
authors.lastname: Gerzer
authors.forename: P
authors.initials: P
authors.lastname: Dominiak
authors.forename: J
authors.initials: J
authors.lastname: Weil
authors.forename: R W
authors.initials: RW
authors.lastname: Beyer
authors.forename: B M
authors.initials: BM
authors.lastname: Kemkes
authors.forename: K
authors.initials: K
authors.lastname: Theisen
mesh_terms: D000328:Adult; D009320:Atrial Natriuretic Factor / Q000097:blood; D006152:Cyclic GMP / Q000097:blood; D004837:Epinephrine / Q000097:blood; D005260:Female; D006333:Heart Failure / Q000097:blood* / Q000601:surgery*; D016027:Heart Transplantation / Q000502:physiology*; D006728:Hormones / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine / Q000097:blood; D011446:Prospective Studies; D012083:Renin / Q000097:blood; D014661:Vasoconstriction / Q000502:physiology; D014664:Vasodilation / Q000502:physiology
chemical_list: D006728:Hormones; D009320:Atrial Natriuretic Factor; D012083:Renin; D006152:Cyclic GMP; D009638:Norepinephrine; D004837:Epinephrine